The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Walder Wyss Ltd

Work +41 58 658 58 58
Fax +41 58 658 59 59

Dr iur Urs Gnos

Work +41 58 658 55 39
Walder Wyss Ltd

Work Department

Corporate / M&A, Capital Markets


Partner; Head Corporate / M&A


Qualified in 1996 (all Swiss courts). From 1997 to 1999 associate at another Swiss law firm. Foreign associate in Chicago and New York in 1999 and 2000. Joined Walder Wyss in 2001. Became partner at Walder Wyss in 2007.


English, German, French


Zurich and Swiss Bar Association; International Bar Association; American Bar Association


University of Zurich (lic. iur.; JD equivalent, 1993), University of Zurich (Dr. iur., 1997); UoP McGeorge School of Law (LL.M. in transnational business practice, 2000)


Commercial, corporate and M&A

Within: Commercial, corporate and M&A

With approximately 50 M&A professionals, sizeable firm Walder Wyss Ltd is renowned for its 'deep commercial understanding, excellent regulatory relationships, as well as its extremely practical and business-oriented advice'. Major highlights include Urs Schenker's assistance to the Burkard family with the CHF3.22bn sale of all shares in Schenker-Winkler Holding to Saint-Gobain, as well as Markus Pfenninger advice to 40 North Latitude Master Fund on its acquisition of a significant stake in Clariant . Practice head Urs Gnos, Alexander Nikitine  and banking M&A specialist Patrick W Vogel, who 'demonstrates outstanding commitment, sound judgement and a deep legal understanding', are other names to note.

[back to top]

Back to index

Legal Developments by:
Walder Wyss Ltd

  • 17 February 2017: Auris Medical's Public Equity Offering

    Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.
    - Walder Wyss Ltd

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to